Cor Vasa 2023, 65(6):877-879 | DOI: 10.33678/cor.2023.021

Coronary evagination after self-apposing stent deployment: a rare but possible event. A clinical case at 4-year follow-up

Giuseppe Venutia, Francesca Consolob, Claudia Morabitoa, Alice Moncadab, Olga La Cognatab, Rosalba De Sarrob, Alessandro Di Carlob, Armando Lo Saviob, Marco Cerritoa
a Department of Cardiothoracic and Vascular Science, Division of Cardiology, Papardo Hospital, Messina, Italy
b Department of Clinical and Experimental Medicine, University of Messina, Italy

Background: Coronary evagination is a coronary abnormality that has been associated with poor long-term outcomes irrespective of the presence of concomitant coronary artery disease (CAD). Its pathogenesis is still not well understood; intracoronary manipulation and percutaneous coronary intervention (PCI) are considered predictors of coronary enlargement through mechanism such as prolonged inflammation, suboptimal endothelialization and vessel positive remodeling. Some stent platforms, like self-apposing stents, seem to be more involved, causing more vessel remodeling. Case presentation: We report the case of a 79-year-old woman who underwent percutaneous coronary intervention (PCI) because of effort angina pectoris; we used a self-apposing stent in a slightly ectatic segment of left circumflex artery and a conventional stent to treat another lesion, with good results. Four years later, a coronary angiography showed an aneurysm surrounding previously implanted self-apposing stent platform; anyway, the coronary flow was normal, so no further intervention was required.

Conclusions: To the best of our knowledge, this is the first paper considering the implication of self-apposing stent properties in evagination generation; this clinical case can be useful to pay attention to patients who underwent percutaneous coronary intervention and received this type of stent.

Keywords: Coronary angiography, Coronary evagination, Self-apposing stent

Received: March 9, 2023; Revised: March 9, 2023; Accepted: March 16, 2023; Prepublished online: June 2, 2012; Published: December 22, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Venuti G, Consolo F, Morabito C, Moncada A, La Cognata O, De Sarro R, et al.. Coronary evagination after self-apposing stent deployment: a rare but possible event. A clinical case at 4-year follow-up. Cor Vasa. 2023;65(6):877-879. doi: 10.33678/cor.2023.021.
Download citation

References

  1. Kawsara A, Núñez Gil IJ, Alqahtani F, et al, Management of Coronary Artery Aneurysms. JACC Cardiovasc Interv 2018;11:1211-1223. Go to original source... Go to PubMed...
  2. Fitzgerald PJ, Otake H. Evaluation of Vessel Response to Percutaneous Coronary Intervention. Rev Española Cardiol (English Ed.) 2008;61:1001-1006. Go to original source...
  3. Radu MD, Räber L, Kalesan B, et al. Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: An optical coherence tomography and intravascular ultrasound study. Eur Heart J 2014;35:795-807. Go to original source... Go to PubMed...
  4. Pellegrini D, Cortese B. Focus on STENTYS® Xposition S Self-Apposing® stent: A review of available literature, Future Cardiol 2019;15:145-159. Go to original source... Go to PubMed...
  5. Morabito C, Casale M, Crea P, et al. Atrial fibrillation and thrombophilia. DOAC as a valid alternative? A clinical case. Cor Vasa 2020;62:470-472. Go to original source...
  6. Dattilo G, Borgia F, Guarneri C, et al. Cardiovascular Risk in Psoriasis: Current State of the Art. Curr Vasc Pharmacol 2019;17:85-91. Go to original source... Go to PubMed...
  7. Casale M, Dattilo G, Imbalzano E, et al. The thromboembolism in COVID-19: the unsolved problem. Panminerva Med 2023;65:51-57. Go to original source... Go to PubMed...
  8. Wilson GJ, Nakazawa G, Schwartz RS, et al. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation 2009;120:141-149. Go to original source... Go to PubMed...
  9. Nakazawa G, Finn AV, Vorpahl M, et al. Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents. J Am Coll Cardiol 2011;57:390-398. Go to original source... Go to PubMed...
  10. Otsuka F, Vorpahl M, Nakano M, et al. Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans. Circulation 2014;129:211-223. Go to original source... Go to PubMed...
  11. John MC, Wessely R, Kastrati A, et al. Differential Healing Responses in Polymer- and Nonpolymer-Based Sirolimus-Eluting Stents. JACC Cardiovasc Interv 2008;1:535-544. Go to original source... Go to PubMed...
  12. Virmani R, Guagliumi G, Farb A, et al. Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent. Circulation 2004;109:701-705. Go to original source... Go to PubMed...
  13. Kleber FX, Schulz A, Köln P. Positive Vessel Remodelling. Eur Med J 2018;111-115. Go to original source...
  14. Bitto R, Casale M, Morabito C, et al. Takotsubo Cardiomyopathy: a Benign Condition or a Bad Omen? Angiology 2018;69:100-102. Go to original source... Go to PubMed...
  15. Corrado E, Dattilo G, Coppola G, et al. Low- vs high-dose ARNI effects on clinical status, exercise performance and cardiac function in real-life HFrEF patients. Eur J Clin Pharmacol 2022;78:19-25. Go to original source... Go to PubMed...
  16. Dattilo G, Bitto R, Correale M, et al. Trend of perceived quality of life and functional capacity in outpatients with chronic heart failure and in treatment with sacubitril/valsartan: a real-life experience. Minerva Cardiol Angiol 2022;70:555-562. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.